Humana Raises 2026 Earnings Forecast to $9.50 Per Share
Humana (HUM) reported Q3 2026 revenue of $41.16B, up 26% YoY, exceeding expectations. Adjusted EPS loss was $0.70, but GAAP net income was $162M. The company raised its 2026 adjusted EPS guidance to at least $9.50 and GAAP EPS forecast to at least $15.09.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise provide a fresh catalyst for the stock, likely prompting buying interest.
Market read
Guidance lift is a primary earnings event with immediate trading relevance.
What to watch
Potential cost pressures from Medicare Advantage contracts could temper upside.
Background
Humana's Q3 results beat revenue expectations and include a significant EPS guidance upgrade.
Ticker impact
Humana raised its full-year adjusted EPS guidance to at least $9.50 per share and reported Q3 revenue of $41.16B, up 26% YoY.
upside pressure as investors price in higher earnings expectations
The guidance lift is a fresh, material disclosure for a large-cap insurer, providing a clear catalyst for short-term buying.
Market effects
Higher earnings expectations may lift the broader health insurance sector.
Positive for U.S. insurers and related financial stocks.
Limited to U.S. markets; no direct global impact.
Counterpoint
If the guidance raise is already priced in, the stock could face a short-term pullback.
Key entities
- companyHumana Inc.
U.S. health insurance provider.
